Exploring the impact of BRCA1 and BRCA2 mutation type and location on Olaparib maintenance therapy in platinum-sensitive relapsed ovarian Cancer patients: A single center report.
Erik ŠkofVida StegelVita Šetrajčič DragošAna BlatnikBrigita GregoričPetra ŠkerlGašper KlančarAnja Zagožen KlasincAlenka BombačMateja KrajcSrdjan NovakovićPublished in: Gynecologic oncology (2024)
ISRCTN42408038, Name of registry: ISRCTN registry, Date of registration: 24/11/2015.